- Report
- December 2021
- 120 Pages
Global
From €3023EUR$3,300USD£2,569GBP
- Report
- November 2021
- 222 Pages
Global
From €2748EUR$3,000USD£2,336GBP
- Report
- October 2021
- 78 Pages
Global
From €733EUR$800USD£623GBP
- Report
- May 2024
- 420 Pages
Global
From €2748EUR$3,000USD£2,336GBP
- Report
- October 2023
- 85 Pages
United States
From €4443EUR$4,850USD£3,776GBP
- Report
- December 2021
- 353 Pages
Global
From €3527EUR$3,850USD£2,997GBP
€5038EUR$5,500USD£4,282GBP
- Report
- September 2021
- 258 Pages
Global
From €3527EUR$3,850USD£2,997GBP
€5038EUR$5,500USD£4,282GBP
- Report
- September 2023
Global
From €4534EUR$4,950USD£3,854GBP
- Report
- September 2023
- 324 Pages
Global
From €4534EUR$4,950USD£3,854GBP
- Report
- January 2023
- 356 Pages
Global
From €4534EUR$4,950USD£3,854GBP
- Report
- June 2022
- 207 Pages
Global
From €2405EUR$2,625USD£2,044GBP
€4809EUR$5,250USD£4,087GBP
- Report
- January 2024
- 140 Pages
Global
From €3023EUR$3,300USD£2,569GBP
- Report
- October 2022
- 510 Pages
China
From €2199EUR$2,400USD£1,869GBP
- Report
- October 2019
Global
From €2565EUR$2,800USD£2,180GBP
- Report
- May 2023
United States
From €1374EUR$1,500USD£1,168GBP
- Report
- March 2023
Germany
From €1374EUR$1,500USD£1,168GBP
- Report
- November 2022
- 197 Pages
United States
From €3435EUR$3,750USD£2,920GBP
- Report
- January 2022
- 292 Pages
Global
From €3435EUR$3,750USD£2,920GBP
- Report
- May 2023
- 240 Pages
Global
From €2519EUR$2,750USD£2,141GBP
€5038EUR$5,500USD£4,282GBP
- Report
- June 2023
- 361 Pages
Global
From €2519EUR$2,750USD£2,141GBP
€5038EUR$5,500USD£4,282GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more